CAS 1474110-21-8

Benzenesulfonamide, N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-[(tetrahydro-2H-pyran-4-yl)methoxy]-

CAS: 1474110-21-8

Formel: C₂₅H₃₅NO₅S

Reinheit: %

Farbe und Form: Solid

Molekulargewicht: 461.6141

Ref: IN-DA001EVF

N-(4-Ethylphenyl)-3-(Hydroxymethyl)-N-Isobutyl-4-((Tetrahydro-2H-Pyran-4-Yl)Methoxy)Benzenesulfonamide

CAS: 1474110-21-8

N-(4-Ethylphenyl)-3-(Hydroxymethyl)-N-Isobutyl-4-((Tetrahydro-2H-Pyran-4-Yl)Methoxy)Benzenesulfonamide

Reinheit: 98+%

Molekulargewicht: 461.61g/mol

Ref: 54-OR1025641

GSK2981278

CAS: 1474110-21-8

GSK2981278

Reinheit: ≥98%

Molekulargewicht: 461.61g/mol

Ref: 54-BUP12794

GSK2981278

CAS: 1474110-21-8

GSK2981278 (ROR gama modulator 1) is a highly potent and selective inverse agonist of retinoic acid receptor-related orphan receptor gamma (ROR gamma).

Formel: C₂₅H₃₅NO₅S

Reinheit: 99.31% - 99.67%

Farbe und Form: Solid

Molekulargewicht: 461.61

Ref: TM-T4050

GSK2981278

CAS: 1474110-21-8

GSK2981278 is a novel investigational product developed by GlaxoSmithKline. It is a potent and selective activator of the transcription factor Nrf2, derived through advanced medicinal chemistry and designed for targeted pharmacological effects. This compound functions by modulating the Nrf2 pathway, which plays a pivotal role in the cellular response to oxidative stress. By activating Nrf2, GSK2981278 aims to enhance the cellular defense systems, thereby mitigating oxidative damage.

Formel: C₂₅H₃₅NO₅S

Reinheit: Min. 95%

Molekulargewicht: 461.61 g/mol

Ref: 3D-ZIC11021